Winston Medical Supply Co., Ltd.(TW:6817)
NT$38.850.80 (-0.26%)
TW:6817
Winston Medical Supply Co., Ltd. financials statements
NT$38.85
At close:0.80 (-0.26%)
Winston Medical Supply Co., Ltd. (6817) Ratios
Winston Medical Supply Co., Ltd. Ratios
TW:6817's free cash flow for Q2 2026 was NT$41.79M. For the 2026 fiscal year, TW:6817's free cash flow was decreased by NT$-163.00K and operating cash flow was NT$41.95M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.99 | 2.01 | 2.01 | 1.89 | 1.75 |
| Quick Ratio | 1.49 | 1.53 | 1.62 | 1.53 | 1.29 |
| Cash Ratio | 0.99 | 0.96 | 1.00 | 0.77 | 0.70 |
| Solvency Ratio | 0.41 | 0.43 | 0.50 | 0.43 | 0.41 |
| Operating Cash Flow Ratio | 0.51 | 0.48 | 0.72 | 0.47 | 0.63 |
| Short-Term Operating Cash Flow Coverage | 3.58 | 2.87 | 4.48 | 3.38 | 3.56 |
| Net Current Asset Value | NT$ 247.77M | NT$ 250.73M | NT$ 225.95M | NT$ 158.67M | NT$ 95.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.13 | 0.13 | 0.13 | 0.16 |
| Debt-to-Equity Ratio | 0.20 | 0.23 | 0.25 | 0.26 | 0.32 |
| Debt-to-Capital Ratio | 0.17 | 0.19 | 0.20 | 0.21 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.08 | 0.10 | 0.12 | 0.14 |
| Financial Leverage Ratio | 1.83 | 1.85 | 1.87 | 1.94 | 1.96 |
| Debt Service Coverage Ratio | 3.14 | 3.07 | 3.79 | 3.90 | 3.03 |
| Interest Coverage Ratio | 119.08 | 136.00 | 128.34 | 128.29 | 62.72 |
| Debt to Market Cap | 0.05 | 0.05 | 0.05 | 0.08 | 0.07 |
| Interest Debt Per Share | 4.78 | 5.66 | 5.91 | 5.18 | 5.82 |
| Net Debt to EBITDA | -1.26 | -1.01 | -0.84 | -0.61 | -0.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.96% | 45.44% | 49.02% | 43.60% | 44.25% |
| EBIT Margin | 20.26% | 23.79% | 28.25% | 23.49% | 22.07% |
| EBITDA Margin | 24.09% | 28.05% | 32.20% | 29.47% | 28.81% |
| Operating Profit Margin | 20.26% | 22.91% | 27.66% | 22.40% | 21.49% |
| Pretax Profit Margin | 20.87% | 23.62% | 28.04% | 23.31% | 21.73% |
| Net Profit Margin | 16.75% | 18.93% | 22.39% | 18.34% | 17.17% |
| Continuous Operations Profit Margin | 16.75% | 18.93% | 22.39% | 18.34% | 17.17% |
| Net Income Per EBT | 80.27% | 80.15% | 79.85% | 78.69% | 79.02% |
| EBT Per EBIT | 103.04% | 103.10% | 101.39% | 104.07% | 101.13% |
| Return on Assets (ROA) | 15.02% | 16.19% | 19.80% | 15.86% | 14.48% |
| Return on Equity (ROE) | 27.43% | 29.95% | 37.10% | 30.76% | 28.32% |
| Return on Capital Employed (ROCE) | 29.62% | 31.73% | 38.98% | 31.02% | 28.57% |
| Return on Invested Capital (ROIC) | 21.67% | 22.92% | 28.25% | 22.44% | 20.43% |
| Return on Tangible Assets | 15.06% | 16.24% | 19.85% | 15.90% | 14.53% |
| Earnings Yield | 7.72% | 7.83% | 8.78% | 9.78% | 6.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.92 | 4.20 | 4.13 | 3.26 | 4.15 |
| Payables Turnover | 9.48 | 6.31 | 7.36 | 8.33 | 9.18 |
| Inventory Turnover | 2.64 | 2.53 | 3.12 | 3.56 | 2.81 |
| Fixed Asset Turnover | 4.19 | 4.10 | 3.88 | 3.21 | 2.47 |
| Asset Turnover | 0.90 | 0.86 | 0.88 | 0.86 | 0.84 |
| Working Capital Turnover Ratio | 2.29 | 2.26 | 2.65 | 2.97 | 4.01 |
| Cash Conversion Cycle | 173.81 | 173.04 | 155.73 | 170.93 | 178.00 |
| Days of Sales Outstanding | 74.14 | 86.82 | 88.42 | 112.08 | 87.92 |
| Days of Inventory Outstanding | 138.18 | 144.05 | 116.86 | 102.66 | 129.86 |
| Days of Payables Outstanding | 38.50 | 57.84 | 49.56 | 43.81 | 39.78 |
| Operating Cycle | 212.31 | 230.87 | 205.29 | 214.74 | 217.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.42 | 8.04 | 11.70 | 6.78 | 8.01 |
| Free Cash Flow Per Share | 7.48 | 6.99 | 10.61 | 6.43 | 7.73 |
| Dividend Paid and CapEx Coverage Ratio | 1.06 | 1.05 | 1.92 | 1.56 | 2.43 |
| Capital Expenditure Coverage Ratio | 8.98 | 7.68 | 10.75 | 19.06 | 28.50 |
| Operating Cash Flow Coverage Ratio | 1.79 | 1.44 | 2.01 | 1.32 | 1.40 |
| Operating Cash Flow to Sales Ratio | 0.22 | 0.21 | 0.30 | 0.21 | 0.27 |
| Free Cash Flow Yield | 9.07% | 7.66% | 10.80% | 10.40% | 10.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.95 | 12.81 | 11.39 | 10.23 | 14.94 |
| Price-to-Sales (P/S) Ratio | 2.17 | 2.42 | 2.55 | 1.88 | 2.57 |
| Price-to-Book (P/B) Ratio | 3.55 | 3.83 | 4.23 | 3.15 | 4.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.03 | 13.05 | 9.26 | 9.62 | 9.75 |
| Price-to-Operating Cash Flow Ratio | 9.80 | 11.35 | 8.39 | 9.11 | 9.41 |
| Price-to-Earnings Growth (PEG) Ratio | -1.22 | -0.74 | 0.27 | 0.52 | -1.33 |
| Enterprise Value Multiple | 7.75 | 7.62 | 7.08 | 5.76 | 8.54 |
| Enterprise Value | 1.31B | 1.48B | 1.62B | 1.03B | 1.32B |
| EV to EBITDA | 7.75 | 7.62 | 7.08 | 5.76 | 8.54 |
| EV to Sales | 1.87 | 2.14 | 2.28 | 1.70 | 2.46 |
| EV to Free Cash Flow | 9.49 | 11.53 | 8.27 | 8.70 | 9.33 |
| EV to Operating Cash Flow | 8.43 | 10.03 | 7.50 | 8.25 | 9.01 |
| Tangible Book Value Per Share | 23.11 | 23.73 | 23.13 | 19.55 | 17.66 |
| Shareholders’ Equity Per Share | 23.22 | 23.86 | 23.23 | 19.64 | 17.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.20 | 0.20 | 0.21 | 0.21 |
| Revenue Per Share | 38.02 | 37.74 | 38.50 | 32.93 | 29.33 |
| Net Income Per Share | 6.37 | 7.15 | 8.62 | 6.04 | 5.04 |
| Tax Burden | 0.80 | 0.80 | 0.80 | 0.79 | 0.79 |
| Interest Burden | 1.03 | 0.99 | 0.99 | 0.99 | 0.98 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.22 | 0.21 | 0.20 | 0.20 | 0.21 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.06 | 0.90 | 1.08 | 1.12 | 1.26 |
Currency in TWD
